Investigational Site Number 643003

Moscow 127018

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Asthma, Ovarian Cancer Recurrent, Relapsing-remitting Multiple Sclerosis, Type 1 Diabetes Mellitus, Venous Thromboembolism

Studies at this site

• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine — Completed
• An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed